Olema Pharmaceuticals (OLMA) Accumulated Depreciation (2020 - 2023)

Olema Pharmaceuticals (OLMA) has 4 years of Accumulated Depreciation data on file, last reported at $698000.0 in Q3 2023.

• On a quarterly basis, Accumulated Depreciation rose 44.21% year-over-year to $698000.0 in Q3 2023; TTM through Sep 2023 was $698000.0, a 44.21% increase from a year earlier, with the FY2022 full-year figure at $581000.0, up 159.38% from the prior year.
• Accumulated Depreciation for Q3 2023 stood at $698000.0, down from $744000.0 in the prior quarter.
• Over the last five years, Accumulated Depreciation for OLMA reached as high as $744000.0 in Q2 2023 and fell as low as $62000.0 in Q4 2020.
• Historically, Accumulated Depreciation has averaged $374833.3 across 4 years, with a median of $350500.0 in 2022.
• Across the five-year window, Accumulated Depreciation surged 340.0% in 2022 and soared 44.21% in 2023, its largest moves.
• Year by year, Accumulated Depreciation stood at $62000.0 in 2020, then surged by 261.29% to $224000.0 in 2021, then surged by 159.38% to $581000.0 in 2022, then increased by 20.14% to $698000.0 in 2023.
• Per Business Quant data, the three most recent Accumulated Depreciation figures were $698000.0 in Q3 2023, $744000.0 in Q2 2023, and $681000.0 in Q1 2023.